We are live on ! Find out more
LVACU

LAVA Medtech Acquisition Corp. Unit
LVACU

Delisted

LVACU was delisted on the 19th of April, 2023.

Back to rankings

14 hedge funds and large institutions have $11.7M invested in LAVA Medtech Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less funds holding

Funds holding: 17 → 14 (-3)

40% less capital invested

Capital invested by funds: $19.6M → $11.7M (-$7.85M)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$44.1K
2
CS
Clear Street
New York
+$9.42K
3
Walleye Capital
Walleye Capital
New York
+$2.01K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$4.04M
2
Millennium Management
Millennium Management
New York
-$1.56M
3
CM
Cohanzick Management
New York
-$562K
4
SSA
Schonfeld Strategic Advisors
New York
-$503K
5
MF
Magnetar Financial
Illinois
-$437K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCA
1
Castle Creek Arbitrage
Colorado
$6.01M – – –
BCM
2
Basso Capital Management
Connecticut
$2M – – –
SSA
3
Schonfeld Strategic Advisors
New York
$1M -$503K -50,033 -33%
CIM
4
Cowen Investment Management
New York
$1M – – –
WC
5
Wealthspring Capital
New York
$420K -$50.3K -5,000 -11%
SIA
6
Schechter Investment Advisors
Michigan
$380K -$50.3K -5,000 -12%
Walleye Capital
7
Walleye Capital
New York
$303K +$2.01K +200 +0.7%
Calamos Advisors
8
Calamos Advisors
Illinois
$251K – – –
LP
9
LMR Partners
United Kingdom
$251K – – –
CS
10
Clear Street
New York
$58K +$9.42K +937 +19%
WAM
11
Wolverine Asset Management
Illinois
$43K +$44.1K +4,382 New
CCM
12
Condor Capital Management
New Jersey
$10K – – –
UBS Group
13
UBS Group
Switzerland
$2K – – –
MF
14
Magnetar Financial
Illinois
$493 -$437K -43,500 -47%
MP
15
Mangrove Partners
Connecticut
– -$4.04M -400,000 Closed
Millennium Management
16
Millennium Management
New York
– -$1.56M -155,000 Closed
CM
17
Cohanzick Management
New York
– -$562K -55,635 Closed
SMA
18
Sage Mountain Advisors
Georgia
– -$105K -10,400 Closed

LVACU Hedge Fund Activity: Q2 2022 in Review

14 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q2 2022, worth a combined $11.7M — down 40% from $19.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LVACU and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $44.1K. The largest seller was Mangrove Partners, exiting entirely with an estimated $4.04M sold.

  • 14 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q2 2022, down from 17 in Q1 2022.
  • Funds reported $11.7M of LAVA Medtech Acquisition Corp. Unit stock for Q2 2022, down 40% quarter-over-quarter.
  • 1 fund opened new LAVA Medtech Acquisition Corp. Unit positions in Q2 2022 and 4 closed out, a net change of -3 holders.
  • The largest LAVA Medtech Acquisition Corp. Unit buyer in Q2 2022 was Wolverine Asset Management, an estimated $44.1K added.
  • The largest LAVA Medtech Acquisition Corp. Unit seller in Q2 2022 was Mangrove Partners, an estimated $4.04M sold.

Based on aggregated 13F filings for Q2 2022.